Patient Registries: An Underused Resource for Medicines Evaluation: Operational proposals for increasing the use of patient registries in regulatory assessments (vol 42, pg 1343, 2019)

McGettigan Patricia; Olmo Carla Alonso; Plueschke Kelly; Castillon Mireia; Zondag Daniel Nogueras; Bahri Priya; Kurz Xavier; Mol Peter G. M.

首页> 外文期刊>Drug safety: An international journal of medical toxicology and drug experience >Patient Registries: An Underused Resource for Medicines Evaluation: Operational proposals for increasing the use of patient registries in regulatory assessments (vol 42, pg 1343, 2019)

【24h】

Patient Registries: An Underused Resource for Medicines Evaluation: Operational proposals for increasing the use of patient registries in regulatory assessments (vol 42, pg 1343, 2019)

机译：患者注册机构：药物评估的未充分利用资源：用于增加在监管评估中使用患者注册管理机构的业务建议（第42卷，PG 1343,2019）

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Drug safety: An international journal of medical toxicology and drug experience》 |2019年第11期|共1页
作者
McGettigan Patricia; Olmo Carla Alonso; Plueschke Kelly; Castillon Mireia; Zondag Daniel Nogueras; Bahri Priya; Kurz Xavier; Mol Peter G. M.;
展开▼
作者单位

Queen Mary Univ London William Harvey Res Inst Charterhouse Sq London EC1M 6BQ England;

European Med Agcy Pharmacovigilance &

Epidemiol Dept Amsterdam Netherlands;

European Med Agcy Pharmacovigilance &

Epidemiol Dept Amsterdam Netherlands;

European Med Agcy Pharmacovigilance &

Epidemiol Dept Amsterdam Netherlands;

European Med Agcy Pharmacovigilance &

Epidemiol Dept Amsterdam Netherlands;

European Med Agcy Pharmacovigilance &

Epidemiol Dept Amsterdam Netherlands;

European Med Agcy Pharmacovigilance &

Epidemiol Dept Amsterdam Netherlands;

Univ Groningen Univ Med Ctr Groningen Dept Clin Pharm &

Pharmacol Groningen Netherlands;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类药品;
关键词

相似文献

外文文献
中文文献
专利

1. Patient Registries: An Underused Resource for Medicines Evaluation: Operational proposals for increasing the use of patient registries in regulatory assessments (vol 42, pg 1343, 2019) [J] . McGettigan Patricia, Olmo Carla Alonso, Plueschke Kelly, Drug safety: An international journal of medical toxicology and drug experience . 2019,第11期

机译：患者注册机构：药物评估的未充分利用资源：用于增加在监管评估中使用患者注册管理机构的业务建议（第42卷，PG 1343,2019）
2. Authors' Reply to Ravi Jandhyala's Comment on "Patient Registries: An Underused Resource for Medicines Evaluation: Operational Proposals for Increasing the Use of Patient Registries in Regulatory Assessments" [J] . McGettigan Patricia, Olmo Carla Alonso, Plueschke Kelly, Drug safety: An international journal of medical toxicology and drug experience . 2019,第12期

机译：作者回复Ravi Jandhyala对“患者登记处：药物评估的未充分利用资源：运营建议增加在监管评估中使用患者注册管理机构”
3. Patient Registries: An Underused Resource for Medicines Evaluation: Operational proposals for increasing the use of patient registries in regulatory assessments [J] . McGettigan Patricia, Olmo Carla Alonso, Plueschke Kelly, Drug safety: An international journal of medical toxicology and drug experience . 2019,第11期

机译：患者注册机构：药品评估的未充分利用资源：用于增加在监管评估中使用患者注册管理机构使用的业务建议
4. PARENT Joint Action: Increasing the Added Value of Patient Registries in a Cross- Border Setting [C] . Matic Meglic, Persephone Doupi, Ivan Pristas, MEDINFO . 2013

机译：父母联合行动：增加跨境环境中患者注册表的附加值
5. Evaluation of the association between quality of life, physical function, and comorbid conditions with survival in prostate cancer patients in CaPSURE(TM) (Cancer of the Prostate Strategic Urologic Research Endeavor) registry. [D] . Sadetsky, Natalia. 2009

机译：在CaPSURE™（前列腺癌战略性泌尿外科研究努力癌症）登记册中评估前列腺癌患者的生活质量，身体功能和合并症与生存之间的关联。
6. Utility of registries for post-marketing evaluation of medicines. A survey of Swedish health care quality registries from a regulatory perspective [O] . Nils Feltelius, Rolf Gedeborg, Lennart Holm, 2017

机译：注册机构在药品上市后评估中的用途。从监管角度对瑞典医疗保健质量注册机构进行的调查
7. Patient Registries: An Underused Resource for Medicines Evaluation [O] . Patricia McGettigan, Carla Alonso Olmo, Kelly Plueschke, 2019

机译：患者注册机构：药品评估的未充分利用资源

Patient Registries: An Underused Resource for Medicines Evaluation: Operational proposals for increasing the use of patient registries in regulatory assessments (vol 42, pg 1343, 2019)

著录项

相似文献

相关主题

期刊订阅